ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
GT Biopharma Inc

GT Biopharma Inc (GTBP)

2.99
0.07
(2.40%)
Closed June 19 4:00PM
2.991
0.001
(0.03%)
After Hours: 7:59PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.99
Bid
2.96
Ask
3.11
Volume
48,157
2.87 Day's Range 3.29
2.61 52 Week Range 11.55
Market Cap
Previous Close
2.92
Open
2.93
Last Trade
20
@
2.96
Last Trade Time
Financial Volume
$ 146,070
VWAP
3.0332
Average Volume (3m)
1,484,948
Shares Outstanding
1,380,633
Dividend Yield
-
PE Ratio
-0.54
Earnings Per Share (EPS)
-5.5
Revenue
-
Net Profit
-7.6M

About GT Biopharma Inc

GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cance... GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
GT Biopharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GTBP. The last closing price for GT Biopharma was $2.92. Over the last year, GT Biopharma shares have traded in a share price range of $ 2.61 to $ 11.55.

GT Biopharma currently has 1,380,633 shares outstanding. The market capitalization of GT Biopharma is $4.13 million. GT Biopharma has a price to earnings ratio (PE ratio) of -0.54.

GTBP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.134.545454545452.863.292.8118228963.04638929CS
4-4.67-60.96605744137.669.592.6111049705.44118709CS
12-1.36-31.26436781614.3510.65992.6114849487.21148277CS
26-4.72-61.21919584957.7110.65992.617368187.17801778CS
52-8.56-74.112554112611.5511.552.614935237.52842503CS
156-526.81-99.4356360891529.8554.6072.6130471664.51795983CS
260-162.01-98.1878787879165591.9932.61336123109.19762137CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CMTLComtech Telecommunications Corporation
$ 4.07
(87.56%)
91.43M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.36M
ASNSActelis Networks Inc
$ 2.11
(83.48%)
51.37M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
LRHCLa Rosa Holdings Corporation
$ 1.78
(71.15%)
52.9M
STISolidion Technology Inc
$ 0.6881
(-64.35%)
16.36M
DMTKDermTech Inc
$ 0.1488
(-55.25%)
10.74M
QMCOQuantum Corporation
$ 0.3752
(-51.90%)
3.14M
ZNTLZentalis Pharmaceuticals Inc
$ 4.135
(-50.72%)
21.58M
AWINAERWINS Technologies Inc
$ 1.74
(-47.90%)
1.05M
RELIReliance Global Group Inc
$ 0.40
(80.18%)
394.85M
NLSPNLS Pharmaceutics Ltd
$ 0.2735
(84.42%)
305.36M
NVDANVIDIA Corporation
$ 135.58
(3.51%)
294.32M
MBIOMustang Bio Inc
$ 0.8517
(13.56%)
291.95M
CRKNCrown Electrokinetics Corporation
$ 0.0548
(-17.10%)
92.39M

GTBP Discussion

View Posts
philaya philaya 4 weeks ago
buy the dip....
low low.
πŸ‘οΈ0
philaya philaya 4 weeks ago
Got in...
Happy losing day.
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 weeks ago
$GTBP solid alerts@MoonMarket_ pic.twitter.com/m5nAAf63ee— THE FINAL COUNTDOWN (@READY_2_PROFIT) May 21, 2024
πŸ‘οΈ0
tw0122 tw0122 4 weeks ago
Didn’t participate in earlier todays squeeze but 100,000 shares available only. Nice continuation
πŸ‘οΈ0
TheFinalCD TheFinalCD 4 weeks ago
GTBP $GTBP

took shorts money, then offered on longs
brutal business this game— GrouchyBear (@GBearTrading) May 21, 2024
πŸ‘οΈ0
Awl416 Awl416 4 weeks ago
LOL
πŸ‘οΈ0
Monksdream Monksdream 4 weeks ago
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
πŸ‘οΈ0
Awl416 Awl416 4 weeks ago
Wils
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 weeks ago
Regarding @RONN, no tip was given to me about it at all --- indeed, the FIRST time I heard about was from YOUR post to me over here.
πŸ‘οΈ0
Invest-in-America Invest-in-America 4 weeks ago
GTBP: Nope; I simply follow the daily posts of iHub's "tw0122", who was the first to post in here on this one.
πŸ‘οΈ0
reena969 reena969 1 month ago
I've been trying to find you Did you take the tip that was given to you?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174447373
πŸ‘οΈ0
govprs govprs 1 month ago
Joker!!! Looks like it’s halted again
πŸ‘οΈ0
bwrbad bwrbad 1 month ago
no future - be at 50c
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 month ago
GTBP: Halted!!
πŸ‘οΈ0
govprs govprs 1 month ago
I’m still holding what’s all the excitement about
πŸ‘οΈ0
Invest-in-America Invest-in-America 1 month ago
GTBP: Still holding --- 4-bagger later today??????
πŸ‘οΈ0
tw0122 tw0122 1 month ago
Moon man summary 90% institutional ownership by Girozentrale on 1m float leaves 100,000 shares for retail to pump. June catalyst
πŸ‘οΈ0
Otis T Otis T 3 months ago
One year price target of $153. Published post split, article available on NASDAQ.com.
πŸ‘οΈ0
Muhbruh Muhbruh 3 months ago
$GTBP recent r/s Bio 1.34m float with 15 months of cash $8.52 cash/sh and no dilution has large pipeline and recently submitted IND application pic.twitter.com/icI6E2OapY— STOCKS Gambino (@StocksGambino) March 12, 2024
πŸ‘οΈ0
Renee Renee 5 months ago
GTBP: effective Feb. 5,2024 a one for 30 reverse split:

https://hedgefollow.com/upcoming-stock-splits.php
πŸ‘οΈ0
Plummy Potter Plummy Potter 10 months ago
Anyone have access to the latest HCW or EF Hutton research reports?
πŸ‘οΈ0
Triple nickle Triple nickle 10 months ago
Nice grab
πŸ‘οΈ0
limer814 limer814 11 months ago
Sure is ,and this sudden burst in volume is telling, added today
πŸ‘οΈ0
Triple nickle Triple nickle 11 months ago
This is the bottom folks
πŸ‘οΈ0
Triple nickle Triple nickle 11 months ago
Weeee
πŸ‘οΈ0
Triple nickle Triple nickle 11 months ago
A little bit
πŸ‘οΈ0
limer814 limer814 11 months ago
Action!!
πŸ‘οΈ0
limer814 limer814 12 months ago
The big three 0
👍️ 1
SittingPretty SittingPretty 12 months ago
saw that too. these bios are beat to hell... should eventually get back some public trust
πŸ‘οΈ0
limer814 limer814 12 months ago
Nice buys coming in
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Nice! Should be hearing something from these guys... hopefully soon.
πŸ‘οΈ0
limer814 limer814 12 months ago
Nice buys coming in
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Regret not waiting... what a crap show lol
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Have to admit, grateful to accumulate at these prices. $GTBP is far along in its process with FDA and others obviously know it. That $175k Form 4 purchase filing last week was telling!
https://www.otcmarkets.com/filing/html?id=16743896&guid=2aT-knKRHtwfJth
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Good morning $GTBP
πŸ‘οΈ0
diskman diskman 12 months ago
Very interesting
👍️ 1
SittingPretty SittingPretty 12 months ago
Good Morning Did you see this? Think we're getting close to some good news. Check it out:

Charles Casamento - Executive Director & Principal - The Sage Group purchased $175k worth of $GTBP @ .35 on 6/16/2023. Filed Form 4 on 06/21/2023
https://www.otcmarkets.com/filing/html?id=16743896&guid=-HT-kenyprHRB3h

Charles J. Casamento is currently Executive Director and Principal of The Sage Group, a healthcare advisory group specializing in mergers, acquisitions, and partnerships between biotechnology companies and pharmaceutical companies, since 2007.
https://www.linkedin.com/in/charles-casamento-b1a9173
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Wow, L2 going crazy. Hopefully this is the flush out and then ready for higher ground!
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Absolutely! Grabbed a bunch a few mins ago. Wow! What a pullback.
πŸ‘οΈ0
Triple nickle Triple nickle 12 months ago
Another day of adding here
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Nice! I'm right here with ya loading Good day for it!
πŸ‘οΈ0
limer814 limer814 12 months ago
Loaded some more today
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Great loading day!
πŸ‘οΈ0
WARHAMMER WARHAMMER 12 months ago
Lol
πŸ‘οΈ0
Triple nickle Triple nickle 12 months ago
Prosperity favors the bold
Can’t never could and won’t never will
👍️ 1
WARHAMMER WARHAMMER 12 months ago
Sounds Dam good to me :)
πŸ‘οΈ0
WARHAMMER WARHAMMER 12 months ago
??!!
πŸ‘οΈ0
Triple nickle Triple nickle 12 months ago
First target 1.12 second one 4.77
πŸ‘οΈ0
SittingPretty SittingPretty 12 months ago
Right here with ya! Once these lower levels consolidate, the move will be nice!
Fingers crossed lol
πŸ‘οΈ0
Triple nickle Triple nickle 12 months ago
Accumulating
👍️ 1

Your Recent History

Delayed Upgrade Clock